Protein Dephosphorylation and Apoptosis in Osteoblast
Protein Dephosphorylation and Apoptosis in Osteoblast
批准号:
09671860
负责人:
HANEJI Tatsuji
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Phosphorylation and dephosphorylation play a central role in the regulation of cellular proliferation and differentiation. It seems likely that the balance between these activities also plays an important parts in apoptosis. Okadaic acid (OA) is a potent inhibitor of protein phosphatases type 1 (PP-1) and type 2A (PP-2A) and increases the phosphorylation of cellular proteins without activation of protein kinase C.We demonstrated that OA induces apoptosis in both Saos-2 cells and MG63 cells in a dose-dependent manner with a maximum effective concentration of 10 nM (Morimoto et al, 1997). Because inhibition of protein phosphatase activity by OA may be a general way of triggering apoptosis in some kinds of cells, it is believed that new protein synthesis is not required for OA-induced apoptosis.To determine if inhibition of the protein synthesis or RNA synthesis could protect against the OA-induced apoptosis in osteoblasts, we cultured the cells in media containing varying concentrations of cycloheximide, actinomycin D, or puromycin in the presence of 10 nM OA.Cycloheximide, actinomycin D, and puromycin significantly protected against OA-induced cytotoxicity and cell death in MG63 cells. The number of apoptotic cells examined by the Hoechst 33342 staining also significantly decreased in MG63 cells treated with these reagents in the presence of OA.Moreover, the intensity of DNA ladder formation was decreased in MG63 cells treated with these reagents in a dose-dependent manner. The maximum effective concentrations of these reagents on the protection of OA-induced apoptosis in MG63 cells are in good agreement with the data concerning thier biological effects in other systems. However, cycloheximide, actinomycin D, and puromycin did not protect against the OA-induced apoptotic cell death in Saos-2 cells determined by the morphological and biochemical techniques (Morimoto et al, in press).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tamura,H.et al.,: "Variability of argyrophilic nucleolar organizer regions in osteoblastic cells." The Journal of the Kyushu Dental Society. 51. 623-628 (1997)
Tamura,H.等人:“成骨细胞中嗜银核仁组织者区域的变异性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haneji, T., Morimoto, H., Morimoto, Y., Shirakawa, S., Kobayashi, S., Kaneda, C., Shima, H.and Nagao, M: "Subcellular localization of protein phosphatase type1 isotypes in mouse osteoblastic cells." Biochemical and Biophysical Research Communications. 248
Haneji, T.、Morimoto, H.、Morimoto, Y.、Shirakawa, S.、Kobayashi, S.、Kaneda, C.、Shima, H. 和 Nagao, M:“小鼠成骨细胞中蛋白磷酸酶 1 型同种型的亚细胞定位
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haneji,T.et al.,: "Subcellular localization of protein phosphatase type 1 isotypes in mouse osteoblastic cells." Biochemical and Biophysical Research Communications. 248. 39-43 (1998)
Haneji,T.等人:“小鼠成骨细胞中 1 型蛋白磷酸酶同种型的亚细胞定位。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tamura, H., Mochizuki, H., Takehara, T., Kobayashi, S.and Haneji, T.: "Variability of argyrophilic nucleolar organizer regions in osteoblastic cells." The Journal of Kyushu Dental Society. 51. 623-628 (1997)
Tamura, H.、Mochizuki, H.、Takehara, T.、Kobayashi, S. 和 Haneji, T.:“成骨细胞中嗜银核仁组织者区域的变异性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Muraki,Y.,et al.: "Localization of Fas antigen in oral squamous cell carcinoma." British Journal of Oral and Maxillofacial Surgery. 37. 37-40 (1999)
Muraki,Y.,et al.:“Fas 抗原在口腔鳞状细胞癌中的定位”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 12 条
The role of PKR on the differentiation of osteoblasts and formation of osteoclasts
-
批准号:25462859
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2013
-
负责人:HANEJI Tatsuji
-
依托单位:
The role of PKR, Osterix, and Calcineurin in osteogenesis
-
批准号:21592330
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:HANEJI Tatsuji
-
依托单位:
Elucidation of the mechanisms of okadaic acid-induced apoptosis and cleavage of nucleolar proteins in osteoblasts
-
批准号:17591915
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2005
-
负责人:HANEJI Tatsuji
-
依托单位:
Protein phosphatases and cleavage of nucleolin in apoptosis-induced osteoblastic cells
-
批准号:15591936
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:HANEJI Tatsuji
-
依托单位:
Protein dephosphorylation and apoptosis in osteoblasts
-
批准号:11671806
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:HANEJI Tatsuji
-
依托单位:
Development of monoclonal antibody for human sperm protein
-
批准号:05671300
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:HANEJI Tatsuji
-
依托单位:
Evaluation of immunological infertility using monoclonal antibody
-
批准号:02670733
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:1990
-
负责人:HANEJI Tatsuji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: